Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Elotuzumab in combination with pomalidomide, bortezomib, ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma
0
Authors
Andrew Yee
22 more
Andrew Yee
•
Jacob Laubach
20 more
•
Noopur Raje
Published
December 3, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Blood Advances
Topics
Physics
Cancer Oncology
Medicine
Internal Medicine
Hematology
Show all topics
DOI
10.1182/bloodadvances.2024014717
License
CC-BY-NC-ND
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Blood Advances
Topics
Physics
Cancer Oncology
Medicine
Internal Medicine
Hematology
Show all topics
DOI
10.1182/bloodadvances.2024014717
License
CC-BY-NC-ND
